Award
NIH Reporter #1R43GM165021-01
Novel Cell Culture Supplement from Adipocyte-Origin Megakaryocytes and Platelets
Recipient
CELL REPROGRAMMING AND THERAPEUTICS, LLC
Award Amount
$422,285.00
Ceiling
$422,285.00
Awarded
August 18, 2026
Identifier
1R43GM165021-01
Award for developing a novel cell culture supplement derived from adipocyte-origin megakaryocytes and platelets, including production, testing, and regulatory certification phases.
Description
The project aims to develop a cell growth supplement from adipocyte-derived megakaryocytes and platelets, competing with existing supplements like FBS and hPL. The project includes phases for production, testing, quality control, and regulatory certification. The market for cell culture supplements is valued at approximately $5.75 billion, projected to reach $12.8 billion by 2030.